COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience.
作者信息
Lucchini Giovanna, Furness Caroline, Lawson Sarah, Gibson Brenda, Wynn Robert, Slatter Mary, Shillitoe Ben, James Beki, Carpenter Ben, Hough Rachael, Amrolia Persis, de la Fuente Josu
机构信息
Bone Marrow Transplant Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Haematology/BMT Unit, Royal Marsden NHS Foundation Trust, London, UK.
出版信息
Br J Haematol. 2021 Aug;194(4):e74-e77. doi: 10.1111/bjh.17547. Epub 2021 Jun 20.
Abstract
摘要
相似文献
1
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience.
Br J Haematol. 2021 Aug;194(4):e74-e77. doi: 10.1111/bjh.17547. Epub 2021 Jun 20.
2
Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19.
Am J Respir Crit Care Med. 2021 Jan 15;203(2):242-245. doi: 10.1164/rccm.202009-3386LE.
3
4
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
Blood. 2002 Dec 15;100(13):4358-66. doi: 10.1182/blood-2002-05-1496. Epub 2002 Aug 22.
5
Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Br J Haematol. 2006 Oct;135(1):76-84. doi: 10.1111/j.1365-2141.2006.06244.x. Epub 2006 Aug 22.
6
Organ Transplantation in the Era of the COVID-19 Global Pandemic.
Isr Med Assoc J. 2021 Mar;23(3):145-146.
7
Renal transplantation during the SARS-CoV-2 pandemic in the UK: Experience from a large-volume center.
Clin Transplant. 2021 Jan;35(1):e14150. doi: 10.1111/ctr.14150. Epub 2020 Nov 23.
8
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002630.
9
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Haematologica. 2016 Feb;101(2):256-62. doi: 10.3324/haematol.2015.135699. Epub 2015 Nov 12.
10
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Bone Marrow Transplant. 2000 May;25(10):1021-8. doi: 10.1038/sj.bmt.1702392.
引用本文的文献
1
COVID-19 infection in children with blood cancer: A systematic review.
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
2
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant.
Clin Hematol Int. 2024 Jul 26;6(3):33-37. doi: 10.46989/001c.121430. eCollection 2024.
3
Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
Clin Infect Dis. 2024 Aug 16;79(2):395-404. doi: 10.1093/cid/ciae133.
4
The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.
Front Immunol. 2023 Aug 25;14:1159269. doi: 10.3389/fimmu.2023.1159269. eCollection 2023.
5
Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation.
Front Oncol. 2023 Jan 17;12:1000215. doi: 10.3389/fonc.2022.1000215. eCollection 2022.
6
Haploidentical CD3 TCR αβ/CD19-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis.
J Allergy Clin Immunol Glob. 2023 Feb;2(1):101-104. doi: 10.1016/j.jacig.2022.08.006. Epub 2022 Oct 4.
7
Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation.
Front Pediatr. 2022 Aug 8;10:935118. doi: 10.3389/fped.2022.935118. eCollection 2022.
8
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Transplant Cell Ther. 2022 Oct;28(10):696.e1-696.e7. doi: 10.1016/j.jtct.2022.06.026. Epub 2022 Jul 4.
9
Case Report: Severe Acute Pulmonary COVID-19 in a Teenager Post Autologous Hematopoietic Stem Cell Transplant.
Front Pediatr. 2022 Mar 3;10:809061. doi: 10.3389/fped.2022.809061. eCollection 2022.
本文引用的文献
1
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.
Br J Haematol. 2021 Mar;192(5):e121-e124. doi: 10.1111/bjh.17260. Epub 2021 Feb 1.
2
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
Transfus Apher Sci. 2020 Oct;59(5):102866. doi: 10.1016/j.transci.2020.102866. Epub 2020 Jul 1.
3
COVID-19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH).
Pediatr Blood Cancer. 2020 Sep;67(9):e28514. doi: 10.1002/pbc.28514. Epub 2020 Jun 23.
4
Thrombotic microangiopathy in a patient with COVID-19.
Kidney Int. 2020 Aug;98(2):509-512. doi: 10.1016/j.kint.2020.05.025. Epub 2020 Jun 7.
5
Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily.
Br J Haematol. 2020 Jun;189(6):e227-e230. doi: 10.1111/bjh.16783. Epub 2020 May 23.
6
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.
7
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
8
A new coronavirus associated with human respiratory disease in China.
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
9
Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in (A20).
Ann Rheum Dis. 2018 May;77(5):783-786. doi: 10.1136/annrheumdis-2016-210944. Epub 2017 Jun 28.
10
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28.
Zotero 插件